The Thermo Fisher Scientific GAD IIS program supports unsolicited, independent investigator-initiated research projects globally. IIS are conceived, designed, and implemented primarily by an external party, and partially supported by Thermo Fisher Scientific by providing products, instruments, and training. As a leader in innovation of real-time PCR, point-of-care PCR, digital PCR, microarray, and Sanger sequencing, Thermo Fisher Scientific’s Genetic Analysis Division (GAD) develops solutions that aim to help facilitate effective decision-making, improve health outcomes, and reduce the cost of patient care. Supported research should align with our areas of interest, enhance understanding of product performance, investigate additional applications of the product, and explore unmet surveillance, clinical, and diagnostic needs. The decision regarding support provided is based on the scientific merit of the proposed research. The IIS program is not an unrestricted grant program. There are contractual obligations tied to the receipt of any support for an IIS proposal.
Our strategic areas of interest are:
1) Infectious disease testing
2) Precision medicine and pharmacogenomics
3) Oncology (Non-NGS) including companion diagnostics
Who may apply
Principal investigators from:
Types of eligible research
The research proposal should align with the company's defined areas of strategic interest and may include:
An applicant can request support for the following:
How to apply
1. Upload a completed study proposal form through the link below. The proposal is a description of how the research will be conducted. This form should not exceed 10 pages, single-spaced, font size of 12. The proposal form includes:
A complete protocol may be requested before the successful endorsement of the study by the review committee. The protocol must be reviewed and approved by the relevant IRB/EC before the contractual agreement is signed. Investigators will assume all responsibilities related to applicable regulatory requirements and ethical standards, including obtaining informed consent of patients referring to Thermo Fisher Scientific’s privacy notice which investigators acknowledge shall apply to any personal data including their own which may be processed by Thermo Fisher Scientific in connection with the study. Thermo Fisher Scientific encourages researchers to register all interventional, prospective, or observational IIS on the FDA’s ClinicalTrials.gov or other trial registry in applicable countries, prior to enrolling subjects.
2. Upload CV of the principal investigator(s)
3. Upload a summary page of research experience in relevant field(s)
Prepare the following documents:
Please send your completed documents here.